Literature DB >> 3170446

Growth control of A431 cells in protein-free medium: secretory products do not affect cell growth.

Y Masuda1, Y Yoshitake, K Nishikawa.   

Abstract

A431 cells grew at similar rates in protein-free Coon's modified Ham's F12 medium (PF-C-F12) with and without added bovine calf serum. The cells secreted a heparin-binding growth factor and a type-beta transforming growth factor, but their growth in PF-C-F12 was not affected by these factors, or by DNA synthesis factor from Rhodamine fibrosarcoma, basic fibroblast growth factor, insulin, human transferrin, bovine serum albumin, and their combinations. Growth of A431 cells in PF-C-F12 was not density dependent and was not affected by either addition of conditioned medium or replacement of conditioned medium by fresh medium. These results indicate that A431 cells have an intracellular mechanism for autonomous growth, and that their growth is not affected by factors that they secrete or by exogenous growth factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170446     DOI: 10.1007/bf02623899

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  28 in total

Review 1.  Fibroblast growth factor.

Authors:  D Gospodarowicz; G Neufeld; L Schweigerer
Journal:  Mol Cell Endocrinol       Date:  1986-08       Impact factor: 4.102

2.  Serum-free cell culture: a unifying approach.

Authors:  D Barnes; G Sato
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

3.  Role of cell shape in growth control.

Authors:  J Folkman; A Moscona
Journal:  Nature       Date:  1978-06-01       Impact factor: 49.962

4.  Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism.

Authors:  W D Cook; D Metcalf; N A Nicola; A W Burgess; F Walker
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.

Authors:  J H Pierce; P P Di Fiore; S A Aaronson; M Potter; J Pumphrey; A Scott; J N Ihle
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

6.  Production and properties of a monoclonal antibody against human epidermal growth factor.

Authors:  S Ikuta; Y Yamada; Y Yoshitake; K Nishikawa
Journal:  Biochem Int       Date:  1985-02

7.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

Authors:  T Kawamoto; J D Sato; A Le; J Polikoff; G H Sato; J Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

8.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.

Authors:  F Cuttitta; D N Carney; J Mulshine; T W Moody; J Fedorko; A Fischler; J D Minna
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

9.  Stimulation of clonal growth of normal fibroblasts with substrata coated with basic polymers.

Authors:  W L McKeehan; R G Ham
Journal:  J Cell Biol       Date:  1976-12       Impact factor: 10.539

10.  Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture.

Authors:  D W Barnes
Journal:  J Cell Biol       Date:  1982-04       Impact factor: 10.539

View more
  10 in total

1.  Extracellular matrix interactions. 1: Production of extracellular matrix with attachment and growth-sustaining functions by UWOV2 ovarian cancer cells growing in protein-free conditions.

Authors:  T Golombick; D R Dajee; W R Bezwoda
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-05       Impact factor: 2.416

2.  Species-specific differences in the mitogenic activity of heparin-binding growth factors in the sera of various mammals.

Authors:  Y Yonezawa; H Kondo; R Hirai; K Kaji; K Nishikawa
Journal:  Experientia       Date:  1992-03-15

3.  Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma.

Authors:  H Watanabe; K Kanbe; M Chigira
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

4.  Direct effect of basic fibroblast growth factor on gene transcription in a cell-free system.

Authors:  Y Nakanishi; K Kihara; K Mizuno; Y Masamune; Y Yoshitake; K Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Expression of basic fibroblast growth factor in hyperplastic parathyroid glands from patients with multiple endocrine neoplasia type I.

Authors:  M Komatsu; S Tsuchiya; I Matsuyama; S Kaneko; Y Suzuki; N Ito; N Hanamura; T Seki; S Kobayashi; T Kuroda
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

6.  Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.

Authors:  K Matsuzaki; Y Yoshitake; Y Matuo; H Sasaki; K Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Autocrine growth induced by transferrin-like substance in bladder carcinoma cells.

Authors:  H Tanoguchi; M Tachibana; M Murai
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Production of basic fibroblast growth factor-like factor by cultured human cholangiocellular carcinoma cells.

Authors:  K Matsuzaki; Y Yoshitake; M Miyagiwa; M Minemura; M Tanaka; H Sasaki; K Nishikawa
Journal:  Jpn J Cancer Res       Date:  1990-04

9.  A quantative in vivo method of analyzing human tumor-induced angiogenesis in mice using agarose microencapsulation and hemoglobin enzyme-linked immunosorbent assay.

Authors:  N Okada; M Fushimi; Y Nagata; T Fukunaga; Y Tsutsumi; S Nakagawa; T Mayumi
Journal:  Jpn J Cancer Res       Date:  1995-12

10.  Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast.

Authors:  T Hasebe; S Imoto; T Ogura; K Mukai
Journal:  Jpn J Cancer Res       Date:  1997-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.